Friday, 26 May 2017

New Zealand News

  • Mylan to develop, market Biocon generic insulin

    New Zealand |  News | By Narayanan Suresh | 0 Comment

    Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US, to sell its three insulin a...Read more

  • Transplant pig cells into human brain to treat Parkinson's

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Health and Disability Ethics Committee to proceed with phase I clinical tr...Read more

  • BioSpectrum Asia launches 5th CRO survey

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSpectrum Asia has now launched the fifth annual survey of the contract ...Read more

  • Largest NZ drug maker to remain a family business

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Douglas Pharmaceuticals, New Zealand's largest pharmaceutical manufacturer, will continue to remain a family owned business. The company had received a number of purchase offer...Read more

  • Nottingham university gets $25 mn for synthetic biology research

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The University of Nottingham has been awarded funding of $4.5 million (£2.9 million) to help make low-carbon fuel. In a move that could potentially revolutionize major UK indu...Read more

  • LCT conducts first implant of regenerative therapy

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment for Parkinson's disease in the first patient in phase I clinical trial....Read more

  • Dr Paul Hutchison: NZ's R&D investment is below OECD's average

    New Zealand |  Influencers | By Vipul Murarka | 0 Comment

    Dr Paul Hutchison, a healthcare professional and a parliamentarian from Hunua, New Zealand, has emerged as one-of-the-most influential individuals when it comes to the life science policies...Read more

  • What functional roles do CROs play in APAC?

    New Zealand |  Analysis | By BioSpectrum Bureau | 0 Comment

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Fisher & Paykel records profit of $62.40 mn

    New Zealand |  Company results | By BioSpectrum Bureau | 0 Comment

    Singapore: Fisher & Paykel Healthcare reported record net profit after tax of $62.40 million (NZ$77.1 million) for the year ended March 31, 2013, an increase of 20 percent as compared t...Read more

  • WHO aims to eliminate TB by 2050

    New Zealand |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: WHO along with European Respiratory Society (ERS), has outlined a framework to work on pre-elimination of tuberculosis (TB) in countries with low levels of the disease and target...Read more

  • BSA-CMR Survey: New CRO players emerge in APAC

    New Zealand |  Analysis | By BioSpectrum Bureau | 0 Comment

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Pictor offers multiple diagnosis with one drop of blood

    New Zealand |  News | By Amrita Tejasvi | 0 Comment

    New Zealand-based Dr Sarita Kumble and Dr Anand Kumble wanted to create an affordable diagnostic test platform that could be deployed in those parts of the world with the highest need. The ...Read more

  • ImmusanT starts trials of celiac disease vaccine, Nexvax2

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed...Read more

  • New Zealand's Biomatters wins Microsoft award

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Biomatters, which is known for developing the Geneious Pro, won the Microsoft Hi-Tech Emerging Company Award at the 2012 NZ Hi-Tech Awards. Dr Brett Ammundsen, director and CEO,...Read more

  • LanzaTech adds oil and gas veteran to its board

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: LanzaTech, a producer of low-carbon fuels and chemicals from carbon-containing gases, appointed of Datuk Ir (Dr) Abdul Rahim Hj Hashim, the current president of the Malaysian Ga...Read more

  • Medical laser market to reach $8.8 bn by 2018: GIA

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, leading to significant rise in the number of procedures carried out u...Read more

  • Fisher & Paykel launches Eson nasal mask

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Bangalore: Auckland-based Fisher & Paykel Healthcare Corp has expanded its nasal mask offering with the F&P Eson nasal mask for use in the treatment of obstructive sleep apnea (OSA)...Read more

  • Lai to head LanzaTech China operations

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: LanzaTech appointed Mr Ken C Lai as VP of its Asia Pacific operations. Based in Shanghai, he will oversee the development and commercialization of the company's gas-to-advanced b...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls